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Conclusions: The novel transport system Portagerm Amies Agar 
allows for a longer survival ofsome of the tested fastidious and anaer- 
obic organisms. 
Serodiagnosis 
I=] IgG EIA test in the diagnosis of human 
brucellosis 
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CYtomepalov& : Sensibiliw- %,96%SpecifitY=83,87%, Agrecment-94,48%. 
Disagreement results were obtained in : toxoplma 13 sera, ~ b e l l a  9 sera, 
cytomegalovirus 2 sera. 
Conclusions: COPALIS techique is a sensitive, specific and easy 
method for the simultaneous detection of Ab against toxoplasma, 
rubella and cytomegalovirus. 
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A.A. Sayiner, D. Ozkaya, S. Giil, A. Zeytinoglu, I. Altuglu, A. 
Bilgic. Microbiology and Clinical Microbiolou, Ege University Medical 
School, Izmir, Turkey 
Objectives: To assess the value of ElA for Brucella-specific IgG as 
compared to classic agglutination tests in the diagnosis of human 
brucellosis. 
Methods: 61 Rose Bengal test (RB) positive and 15 RB negative 
sera were evaluated by serum agglutination test (SAT), 2-mercap- 
toethanol test (2ME), Coombs test and commercial Brucella IgG EIA 
test (Clark Lab., USA). 
Results: 56 of 59 patient sera which were RB(+), SAT(+) and 
2ME(+) were found to be positive by Brucella IgG EIA. Nine sera 
had 2ME titer of 20. Two of these were EIA negative and one was 
repeatedly equivocal, while the remaining six were EIA positive. 
There were 15 RB(-), SAT(-) and Coombs (-) sera, among which 
one gave a positive reaction with EIA test. Two patients who were 
a(+) and SAT(+), but 2ME (-), were also found negative by 
Brucella IgG EIA. When RB, SAT and 2ME positivity were accepted 
as the gold standard, the sensitivity of the Btucella IgG EIA test was 
94.9%, and the specificity was 94.4%. The IgG EIA test could deter- 
mine all patients with 2ME titer 40. 
Conclusions: The commercially available Brucella IgG EIA may 
replace the 2ME test for detecting specific IgG but is insensitive in 
patients with 2ME titer <40. 
lp8331 Coupled particle scattering (COPALIS): new 
technology for simultaneous serodiagnosis 
MJ. Ramos, A.Gonzalez-Ruiz, S. Perea, C.P. Alvarez, A.Gonzalez- 
Escalada, I. Martinez, A. Fuertes. Hospital 12 de Octubre, Madrid, 
Spain 
Objectives: To compare the COPALIS technique (DiaSorin, Spain) 
versus EIA (Sera Quest, Diagnostic Grifols, S.A.) for the simultane- 
ous detection of antibodies (Ab) against toxoplasmosis, rubella and 
cytomegalovirus. 
Methods: 264 sera were tested for the simultaneous detection of 
toxoplasma, rubella and cytomegalovirus antibodies. COPALIS is a 
homogeneous immunoassay technology that permits simultaneous 
detection of multiple analytes in serum, plasma or whole blood. It 
differentiates monomeric latex particles &om latex aggregates on the 
basis of their unique light scatter properties. Multiple simultaneous 
assays are configured by the use of mixtures of different-size latex 
microparticles. EIA test was considered the reference method. 
Additionally, we used a more sensitive latex agglutination test to 
rubella and toxoplasma (Pastorex, Sanofi Diagnostics Pasteur) and to 
cytomegalovirus (CMVERSUScan, Becton Dickinson) to evaluate 
disagreement results. 
Results: 
Comparison of the microscopic agglutination 
test and the rapid microscopic agglutination 
test in the diagnosis of bovine leptospirosis 
A P. Lage, EH.S. Guitnaees, A.O. Pellegrin, J.E Figueiredo, E.C. 
Moreira. Escola de Veterindria, Universidade Federal de Minas Gerais, 
Belo Horizonte, Brazil 
Introduction: Identification of Leptospira intenogans serovars Infect- 
ing cattle in a herd is of major concern in the control of bovine 
leptospirosis, and is based on serovar-specific vaccines. The method 
recommended by OMS and OIE for the dlagnosis of bovine and 
human leptospirosis is the microscopic agglutination test (MAT). In 
1970, Ryu (1970) proposed a rapid microscopic agglutination test 
(RMAT) that reduces non-specific reactions. 
Objectives: The present study compared the RMAT to the MAT 
in the detection of anti-L. hardjo antibodies in bovine serum. 
Methods: A hundred and eighteen bovine sera from 10 herds 
were tested by MAT and RMAT. Seven-day-old L. kardjo cultures 
with a concentration of 100 microorganisms per microscopic field 
(400X) were used as antigen. Sera (100 pL) diluted 1/100 and mixed 
with the same volume of antigen were incubated at room tempera- 
ture for 2 h in the MAT and for 5 min in the RMAT. Sera that 
presented 50% or more agglutination in a test were classified as posi- 
tive for L. harj'o antibodies. Positive sera were diluted from 1/100, on 
a twofold basis, up to a final titer. 
Results: Forty-four sera were positive by the MAT and 40 by the 
RMAT. The mean titers found were 800 for MAT and 1600 for 
RMAT. The McNemar test showed no significant difference 
between the two tests ( ~ ~ 0 . 3 9 )  and the kappa statistics showed a 
good agreement between MAT and RMAT (kappa=0.78). When 
the final titers by the two methods were compared, no significant 
dlfferences were found (t=-0.27, p=0.79) and RMAT was highly 
correlated with MAT (r2=0.81). 
Conclusions: These results show that RMAT has a good agree- 
ment with MAT in the detection of L. kardjo antibodies in bovine 
sera, and has the advantage of being a faster test. 
lp8351 Coupled particle light scattering (Copalis), a 
new technology for cytomegalovirus (CMV), 
rubella and toxoplasma serodiagnosis 
A. Gonzalez Ruiz, MJ. Ramos, C. Alvarez, M.J. Domingo, M. 
Garau, A. Gonzalez-Escalada, M.C. Pazos, A.R. Noriega, A. 
Fuertes. Microbiology Department, Hospital 12 de Ortubre, Madrid, 
Spain 
Objectives: To compare the COPALIS System (DiaSorin, Spain) 
versus EIA (SeraQuest, Diagnostic Grifols, S.A.) for the detection of 
antibodies (Ab) against CMV, rubella and toxolasma. 
Methods: One hundred and sixty-three sera were tested to CMV 
Ab, 265 to toxoplasma and 72 to rubella Ab. COPALIS is a homo- 
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multiple analytes in serum, pllasma or whole blood, differentiating 
monomeric latex particles from latex aggregates and cells on the 
basis of the light scatter properties. EIA test was considered the refer- 
ence method. Additionally, we used latex agglutination tests controlled by encouraging quinolone usage 
(CMVEKSUScan, Becton Dickinson, Pastorex toxo and rubella, 
Sanofi Diagnostics Pasteur) to evaluate disagreement results. 
lp837) An outbreak of enterococcal infection 
A.E Fraise', S. Bass', B. Cunningham', M.J. Gill', K. Wise', P.M 
Hawkey'. 'Department of Patholqx City Hospital ,VHS Tnrst, Results: The results are showed in the tables below: 
Sensibility(%) Specificity(%) Agreement(%) 
CMV 96.96 83.87 94.47 
Rubella I on 91.66 94.22 
Toxoplsrma 97.36 94.59 95.40 
Conclusions: COPALIS is a sensitive, specific and acceptable 
method for the detection of Ah against CMV, rubella and toxo- 
plasma. 
lp8361 Comparison of serologic tests and bone 
marrow aspiration for the diagnosis of visceral 
leishmaniasis 
E. Cani', M.T. Schick', G. Kuli', 13. Kraja', N. Xhyhed.  
'Departmmt qffnfirrobiolo,gx Inrtiture of Public Health, u/HO/HM, 
University Hospital Center, Tirana, Albania 
Objectives: To establish the method of choice for the diagnosis of 
visceral leithmaniasis in Albania. 
Methods: Sera from 115 p e n t s  hospitalized at the Universiry 
Hospital Center Tirana betwemen 1995 and 1997 were analyzed for 
IgC antibodies against Leisltrnavia infanturn by direct agglutination and 
a new, not yet commercially available, ELISA test (Laboratoires 
Bordier, Lausanne, Switzerland). The results were compared to thote 
from bone marrow aspiration. The ELISA test was also performed 
on 44 sera from healthy blood donors. 
Results: In total, 112 samples were positive for IgG antibodies 
both with direct agglutination and with ELISA. Bone marrow aspi- 
ration resulted in 109 cases confirmed by microscopy afier staining 
with GIEMSA; i.e. 3 patients with a positive serology from both tests 
used were not picked up by bone marrow aspiration. Another 3 
patients were clinically suspected cases, but neither one of the sero- 
logic tests nor bone marrow aspiration could confirm the diagnosis. 
All 44 samples from healthy blood donors analyzed by ELISA were 
negative. 
Conclusions: The two serologic methods gave 100% concordant 
rcsults. In 3% of the patients, bone marrow aspiration failed to iden- 
tify the cases. In our study, the specificity of the new ELISA test was 
100%. Since the serologic tests used in our study were more sensitive 
than bone marrow aspiration and serology is clearly far less invasive, 
we reconimend the use of either direct agglutination or ELISA, the 
choice between the two depending on the availability and the costs 
involved. 
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Cephalosporins are known to be an important risk factor for ente- 
rococcal infection. During a period when ceftazidiiiie (CAZ) use on 
a 7-bed intensive care unit (ITU) averaged 22.4 defined daily dore5 
(DDDs) per month, we identified an outbreak of enterococcal infec- 
tion. There was a greater than 10-fold increase in the rate of isola- 
tion ofinfecting enterococci over a 15-month period (5.5 isolates per 
1000 bed days at the beginning compared with 66 isolates per 1000 
bed days at the end). Microbiological saiiipling did not alter over this 
period and isolates were associated with clinical evidence of infec- 
tion. The increase was mainly due to E. fecalis (69 isolates), which 
repi-esented 1%) of all Gram-positive isolates in the first 3 inoiiths but 
41% in the last 3 months (P<0.001). Pulsed-field gel electrophore- 
sis of Stria1 chromosome digests showed two distinguishable strains of 
E.fecolis with some associated cross-infection. In addition there were 
infections due to E.faecinrn (9 isolates), E. dnronr (2 isolates) and other 
species of enterococci (5 isolates) . Following a change from 
cephalosporin use to ciprofloxacin use, the prevalence of enterococ- 
cal infection was monitored for a further 12 months, during which 
time there were no changes in microbiological or infection control 
procedures. Ceftazidime use decreased from 22.4 to 5.1 DlXIs 
per month and quinolone usage increased from 16.9 to 32 DDDs per 
month. Enterococcal isolates decreased from 92 to 10.2 isolatrs per 
1000 bed days in the first and last quarters ofquinolone use. Although 
quinolones have poor activity against enterococci, they niay not 
disturb the bowel flora as much as cephalosporins. Replacenient of 
cephalosporins with quinolones may assist in the control of outbreaks 
of enterococci. 
lp8381 Antibiotic resistance in clinical isolates of 
enterococci from North-Rhine Westphalia and 
analysis of clonal relatedness of glycopeptide- 
resistant strains from German hospitals 
I .  Klare', G. Werner', G. Conrads', JJ Schlaeger', K. Lutticken', 
W. Witte', R.K. Reinert'. 'Robert Kocli Institute, Wm<qerodt., 
ZNational Referetzre Center.fir Streptococci, Urlivrrsity Hospital Aatlierz, 
Germany 
Objectives: Antibiotic i-esistance rates and genotyping of eiitt'ro- 
cocci. 
Methods: Agar dilution teyt, macrorestriction analysis, platniid 
isolation and restriction analysis, hybridization. 
Results: In 1997, clinical isolates of enterococci (n=730; one 
strain per patient) originating from 22 microbiological laboratories in 
North-Rhine Westphalia (Germany) were analyzed. These strains 
(n/%j were isolated froni: urogenital tract (312/42.7), wounds 
(165/23.0), respiratory tract (79/10.8), blood (68/9.3), catheter or 
drainage (39/5.4), CNS (4/0.6), other sources (60/8.2j. They 
included the enterococcal species E. feralir (648/88.9), E. ,faerilrnz 
(72/9.8), E. hirae, E .  aviitm, E.  casse@ovics (each ofthose: 3/0.4), and 
E. durans (1/0.1 j .  The following percentages of antibiotic resistance 
(all enterococci/E. fe ra l i s /€ .  faecirrnt) were determined ampicillin 
(7.4/0.9/66.7), high-level gentaiiiicin ( I  5.0/ 14.81 18. l ) ,  high-level 
streptomycin (28.1 /25.6/52.8), ciprofloxacin (37.9/ 33.8/81 .Y), vaiico- 
mycin (1.5/0.5/11.1), teicoplanin (1.5/0.5/11.1). All glycopeptide- 
